Allied Market Research

Smart Strategies for the Growth of – Diabetic Neuropathy Treatment Market

Diabetic Neuropathy Treatment Market Size is Set to Grow at a Remarkable Pace in the Coming Years.

 

Portland, OR -- (SBWIRE) -- 08/25/2017 -- Diabetic neuropathy is a nerve damaging disorder associated with diabetes mellitus. Patients suffering from diabetes since a long time are prone to nerve damages throughout the body, as the symptoms of diabetic neuropathies cannot be diagnosed at an earlier stage. Although there is no cure for diabetic neuropathy, it can be suppressed or prevented using various treatment modalities.

Access full summary at: https://www.alliedmarketresearch.com/diabetic-neuropathy-treatment-market

The global diabetic neuropathy market is driven by increase in prevalence of diabetes due to sedentary lifestyle, rise in obese population due to improper diet, and growth in awareness regarding diagnosis & treatment of diabetes. However, high cost of treatment for diabetic neuropathy and side effects associated with the drugs hinder the market growth. On the contrary, rise in demand for the development of better neuropathy drugs is expected to present numerous opportunities for the market growth in the near future.

The key companies profiled in this report include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Johnson & Johnson, GlaxoSmithKline plc., Lupin Limited, Glenmark Pharmaceuticals Limited, Depomed, Inc., Astellas Pharma Inc., and Pfizer Inc.

Diabetic Neuropathy Treatment Market Key Segments

By Disorder
- Peripheral Neuropathy
- Autonomic Neuropathy
- Proximal Neuropathy
- Focal Neuropathy

By Treatment
- Drugs
o Analgesics
* Topical
* Capsaicin
* Others
* Opioid
* Morphine
* Others
* NSAIDs (Non-steroidal Anti-inflammatory Drugs)
* Ibuprofen
* Naproxen
* Others

o Anti-depressants
* TCAs (Tricyclic Anti-depressants)
* Amitriptyline
* Imipramine
* Others
* SNRIs (Selective Nor-epinephrine Reuptake Inhibitors)
* Duloxetine
* Others
* SSRIs (Selective Serotonin Reuptake Inhibitors)
* Citalopram
* Paroxetin
* Others

o Anti-convulsant

* Gabapentin
* Pregabalin
* Topiramate
* Others

o Other Drugs
o
- Radiotherapy
- Physiotherapy
- Others

By Distribution Channel
- Hospitals
- Clinics
- Pharmacy

By Region
- North America
o U.S.
o Canada
o Mexico

- Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe

- Asia-Pacific
o China
o India
o Japan
o Rest of Asia-Pacific

- LAMEA
o Brazil
o South Africa
o Saudi Arabia
o Rest of LAMEA

Request TOC and Sample Report: https://www.alliedmarketresearch.com/request-toc-and-sample/2578

About Allied Market Research
Allied Market Research is a Market Research Company which offers Syndicate & Custom Market Research Reports with Consulting Services.

Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
United States.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com